Add to ORKGThis item is only available electronically.Thesis (BHlthMSc(Hons)) -- University of Adelaide, Adelaide Medical School, YEA
Background and objectives: An increasing number of cancer patients have described experiencing cogni...
Chemotherapy-induced cognitive impairment (CICI) occurs in a substantial proportion of treated cance...
Chemotherapeutic agents such as doxorubicin, cyclophosphamide, fluorouracil, and cisplatin are commo...
Patients with acute lymphoblastic leukemia have a high five-year survival rate thanks to methotrexat...
Methotrexate (MTX) is a cytostatic agent widely used in combination with other agents as adjuvant ch...
Patients with acute lymphoblastic leukemia have a high five-year survival rate thanks to methotrexat...
Methotrexate (MTX) is a cytostatic agent widely used in combination with other agents as adjuvant ch...
Methotrexate (MTX) is a cytostatic agent widely used in combination with other agents as adjuvant ch...
Methotrexate (MTX) is a cytostatic agent widely used in combination with other agents as adjuvant ch...
Methotrexate (MTX) is a cytostatic agent widely used in combination with other agents as adjuvant ch...
Methotrexate (MTX) is a cytostatic agent used in adjuvant chemotherapy for treatment of breast cance...
Abstract Background In this study, we examined the effects of cyclophosphamide, methothrexate, and 5...
Patients receiving chemotherapy frequently experience debilitating side-effects. Side-effects such a...
Abstract Background In this study, we examined the effects of cyclophosphamide, methothrexate, and 5...
Rationale: CMF (cyclophosphamide: CP; methotrexate: MTX; 5-fluorouracil: 5-FU) is a chemotherapy com...
Background and objectives: An increasing number of cancer patients have described experiencing cogni...
Chemotherapy-induced cognitive impairment (CICI) occurs in a substantial proportion of treated cance...
Chemotherapeutic agents such as doxorubicin, cyclophosphamide, fluorouracil, and cisplatin are commo...
Patients with acute lymphoblastic leukemia have a high five-year survival rate thanks to methotrexat...
Methotrexate (MTX) is a cytostatic agent widely used in combination with other agents as adjuvant ch...
Patients with acute lymphoblastic leukemia have a high five-year survival rate thanks to methotrexat...
Methotrexate (MTX) is a cytostatic agent widely used in combination with other agents as adjuvant ch...
Methotrexate (MTX) is a cytostatic agent widely used in combination with other agents as adjuvant ch...
Methotrexate (MTX) is a cytostatic agent widely used in combination with other agents as adjuvant ch...
Methotrexate (MTX) is a cytostatic agent widely used in combination with other agents as adjuvant ch...
Methotrexate (MTX) is a cytostatic agent used in adjuvant chemotherapy for treatment of breast cance...
Abstract Background In this study, we examined the effects of cyclophosphamide, methothrexate, and 5...
Patients receiving chemotherapy frequently experience debilitating side-effects. Side-effects such a...
Abstract Background In this study, we examined the effects of cyclophosphamide, methothrexate, and 5...
Rationale: CMF (cyclophosphamide: CP; methotrexate: MTX; 5-fluorouracil: 5-FU) is a chemotherapy com...
Background and objectives: An increasing number of cancer patients have described experiencing cogni...
Chemotherapy-induced cognitive impairment (CICI) occurs in a substantial proportion of treated cance...
Chemotherapeutic agents such as doxorubicin, cyclophosphamide, fluorouracil, and cisplatin are commo...